EG ·
kansartan 300MG 02/TAB
kansartan 300MG 02/TAB
Composition
These source-reported data require scientific review and are not treatment advice.
IRBESARTAN
· AMOUNT_PER_UNIT
IRRBESARTAN
· AMOUNT_PER_UNIT
Registration
Packages and prices
Explainable alternatives
Candidates are informational and are not automatic authorization for substitution or dispensing.
| Product | Match | Differences | Price |
|---|---|---|---|
| kansartan 300MG 10/TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| kansartan 150 MG tab 10 | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| kansartan 75MG 10/TAB | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| kansartan 150 MG tab 30 | EXACT_PHARMACEUTICAL_COMPOSITION | — | — EGP |
| kansartan 150 20 tab | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| IRBEDRIN 300 MG 10 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |
| COAPROVEL 150\12.5 MG 14 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| IRBEDRIN 75MG 14TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, dosage_form, route | — EGP |
| co approval 300 mg tab | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| CO APROVEL 300MG/12.5MG 14/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| COAPROVEL 150\12.5MG 28/TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis, route | — EGP |
| KANSARTAN 300 MG 30 TAB | PARTIAL_INGREDIENT_OVERLAP | substance_identity, active_moiety, strength_or_basis | — EGP |